Glaukos

Growing number of devices set to transform glaucoma treatmentMinimally invasive glaucoma surgery (MIGS) is the latest development in the treatment of glaucoma. With two MIGS devices already approved in the United States, there are a variety of novel devices that have the potential to transform the treatment of glaucoma.
Evolution in glaucoma surgery mounting with MIGS proceduresAn expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery procedures is transforming glaucoma management.
Glaucoma micro-stent’s 2-year data promisingTake-home: With the approval of a new surgical device aimed at lowering IOP, surgeons explore benefits of micro-stent implantation.
MIGS making big difference in glaucoma managementMicroinvasive glaucoma surgery devices already have transformed the management of glaucoma and will have a bigger impact in the future considering the options in the investigational pipeline and the opportunities they present.
A bullish view: Navigating beyond glaucoma company mistakesCompanies specializing in glaucoma products can make billions of dollars, but only if they can find a path through a minefield of scientific, regulatory, and marketing hazards, according to Richard A. Lewis, MD.
CPT coding for glaucoma surgery reporting undergoes changesGlaucoma specialists and general ophthalmologists alike must be aware of some significant procedure coding changes that will increase the complexity of the glaucoma surgical code set.
New glaucoma devices bring new dimension of treatment
MIGS devices show encouraging initial results
MIGS brings balance to combined cataract-glaucoma surgery
In the pipeline: Novel MIGS stents in various stages of trialsNew devices to lower IOP and facilitate aqueous outflow via minimally invasive glaucoma surgery are being developed, and early results from clinical trials are favorable for some.